Overexpression of the ASCT2 transporter in BCMA-CAR T cells boosts their metabolic fitness, leading to superior tumor control and prolonged survival in preclinical multiple myeloma studies. https://mappingignorance.org/2026/07/08/enhanced-bcma-car-t-cell-therapeutic-efficacy-in-multiple-myeloma/

0 likes 0 replies